Quarterlytics / Healthcare / Biotechnology / Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

MCRB · NASDAQ Healthcare
Claim this profile
Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 103
Overview Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management
Company Profile
Seres Therapeutics’ microbiome pivot: can SER-155 outrun the cash clock?
On Seres Therapeutics’ Q3 2025 earnings call, Co-CEO and CFO Marella Thorell stressed that the company’s $8.2 million profit was entirely the product of a $27.2…
MCRB Jun 18, 2026